A Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung Cancer
Clinical trial NCT02976116 · COMPLETED
Trial details
- NCT number
- NCT02976116
- Sponsor
- Hutchison Medipharma Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2019-06-28
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.